Skip to main content
Prasad Kulkarni, MD, Gastroenterology, Tampa, FL

PrasadMKulkarniMD

Gastroenterology Tampa, FL

Professor of Medicine, University of South Florida

Dr. Kulkarni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kulkarni's full profile

Already have an account?

  • Office

    13000 Bruce B Downs Blvd
    111b
    Tampa, FL 33612
    Phone+1 813-972-2000
    Fax+1 813-903-4812

Education & Training

  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityFellowship, Gastroenterology, 1997 - 2000
  • Wayne State University School of Medicine
    Wayne State University School of MedicineResidency, Internal Medicine, 1994 - 1997
  • B.J. Medical College - University of Pune
    B.J. Medical College - University of PuneClass of 1982

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2002 - 2026
  • MI State Medical License
    MI State Medical License 1997 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Fellow (AGAF) American Gastroenterological Association
  • Fellow (FACG) American College of Gastroenterology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Hopeful of Launching Covovax for Adults in October This Year, for Children in Q1-2022: Serum CEO
    Hopeful of Launching Covovax for Adults in October This Year, for Children in Q1-2022: Serum CEOAugust 6th, 2021
  • Govt Panel Recommends Nod to SII for Part 2/three Trials of Covovax on Kids Aged 2-17
    Govt Panel Recommends Nod to SII for Part 2/three Trials of Covovax on Kids Aged 2-17July 27th, 2021
  • Expert Panel Recommends Nod to SII for Phase 2/3 Trials of Covovax on Children Aged 2-17
    Expert Panel Recommends Nod to SII for Phase 2/3 Trials of Covovax on Children Aged 2-17July 27th, 2021
  • Join now to see all

Professional Memberships